Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin crossover study in painful diabetic peripheral neuropathy with pain on walking
2011-003266-32Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in diabetic polyneuropathy (DPN) (2 arms), sponsored by Pfizer. Primary endpoint: Co-primary efficacy endpoints. Started Oct 2011; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2011-003266-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003266-32.